Human metabolic transformation of quercetin blocks its capacity to decrease endothelial nitric oxide synthase (eNOS)...

Area of Science:

• Biochemistry
• Cardiovascular Research
• Nutritional Science

Background:

• Quercetin, a dietary flavonol, impacts endothelial function and blood pressure.
• Quercetin undergoes extensive metabolism during absorption.
• Endothelial nitric oxide synthase (eNOS) and endothelin-1 (ET-1) are crucial for endothelial homeostasis.

Purpose of the Study:

• To investigate how quercetin and its human metabolites affect eNOS and ET-1 expression.
• To determine if quercetin's metabolites retain its biological activity on endothelial cells.

Main Methods:

• Human Umbilical Vein Endothelial Cells (HUVEC) were used.
• Cells were treated with quercetin aglycone, its metabolites, and Tumor Necrosis Factor-alpha (TNFα).
• eNOS and ET-1 gene and protein expression levels were measured.

Main Results:

• Quercetin aglycone significantly reduced eNOS expression, similar to TNFα.
• Quercetin metabolites did not affect eNOS expression, even with TNFα.
• Quercetin reduced ET-1 expression, while metabolites had minimal effect, except quercetin-3'-sulfate.
• Quercetin-3'-sulfate moderately increased ET-1 in TNFα-stimulated cells.

Conclusions:

• Quercetin metabolism transforms it into compounds that do not reduce eNOS expression.
• Metabolic transformation of quercetin may prevent potentially harmful decreases in eNOS in endothelial cells.
• This suggests a protective role for quercetin metabolism in maintaining endothelial function.